Atomoxetine in adolescents with attention deficit hyperactivity disorder (ADHD) and substance use disorder (SUD).
Phase of Trial: Phase IV
Latest Information Update: 06 Nov 2012
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder; Substance-related disorders
- Focus Therapeutic Use
- 30 Jul 2008 Updated from NCT (via DMS 30-07-08).
- 27 Jul 2008 The expected completion date for this trial is now 1 Sep 2012.
- 05 Nov 2005 New trial record.